QA: TG THERAPEUTICS INC. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001001316_2017_TG_THERAPEUTICS_INC.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001001316')"}

Graph

Absolute values for 0001001316, TG THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 50,864,144
1 IntangibleAssetsNetIncludingGoodwill 799,391
2 PropertyPlantAndEquipmentNet 328,148
3 remainder_Assets 2,789,864
4 LiabilitiesCurrent 16,878,440
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,035,305
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,889,335
9 ResearchAndDevelopmentExpense 69,232,174
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 868,615
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 54,781,547
1 Liabilities 18,913,745
2 Expenses 79,121,509
3 Revenues 0
4 StockholdersEquity 35,867,802
5 NetIncome -78,252,894
6 ComprehensiveNetIncome -78,252,894
7 BaseVar 76,842,708
8 EconomicCapitalRatio -0.449

Edgar->Model Mapping

Feature Distribution